Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Background Whereas safe, curative treatments for hepatitis C virus (HCV) have been available since 2015, there are still 58 million infected persons worldwide, and global elimination may require new paradigms. We sought to understand the acceptability of approaches to long-acting HCV treatment....

Full description

Bibliographic Details
Main Authors: Weld, Ethel D, Astemborski, Jacqueline, Kirk, Gregory D, Sulkowski, Mark S, Katz, Stephanie, Rothman, Richard, Solomon, Sunil S, Matthews, Gail V, Hsieh, Yu Hsiang, Verma, Malvika, Traverso, Giovanni, Swindells, Susan, Owen, Andrew, Feld, Jordan, Flexner, Charles, Mehta, Shruti H, Thomas, David L
Format: Article
Language:English
Published: Oxford University Press 2024
Online Access:https://hdl.handle.net/1721.1/155049

Internet

https://hdl.handle.net/1721.1/155049

Similar Items